R&D leaders

Companies spending the largest share of their revenue on research and development. High intensity is a claim about the future, not evidence about it, which is why the balance sheet sits in the table beside it.

23 companies pass today. Recomputed nightly from SEC filings and end-of-day closes.

Highest R&D Spending as a Share of Revenue
CompanySectorMarket capP/EFCF yield1 year
DDOGDatadogTechnology$79Bn/a1.4%+72%
SNOWSnowflake Inc.Technology$79Bn/a1.5%+1.8%
ALNYAlnylam Pharmaceuticals, Inc.Healthcare$39B123.71.2%-9.8%
SNPSSynopsys, Inc.Technology$89B115.33.0%-1.5%
VRTXVertex PharmaceuticalsHealthcare$121B27.83.1%+7.1%
METAMeta PlatformsCommunication Services$1.4T20.03.4%-20%
MRVLMarvell Technology, Inc.Technology$246B99.40.7%+275%
AMDAdvanced Micro DevicesTechnology$848B169.21.0%+301%
ADSKAutodeskTechnology$41B36.35.9%-36%
NOWServiceNowTechnology$97B55.34.8%-52%
CIENCienaTechnology$66B286.71.1%+514%
EWEdwards LifesciencesHealthcare$52B47.42.1%+19%
AVGOBroadcomTechnology$1.8Tn/a1.6%+52%
INTUIntuitTechnology$73B16.815%-65%
GRMNGarminConsumer Cyclical$46B26.63.1%+21%
GOOGLAlphabet Inc.Communication Services$4.9T26.11.3%+110%
CRMSalesforceTechnology$142B19.010%-42%
MPWRMonolithic Power SystemsTechnology$70B103.70.9%+109%
PLTRPalantir TechnologiesTechnology$272B119.11.0%-19%
MSFTMicrosoft CorporationTechnology$3.1T21.72.4%-24%
DASHDoorDashConsumer Cyclical$77B83.72.8%-23%
BSXBoston ScientificHealthcare$66Bn/a5.3%-57%
MUMicron TechnologyTechnology$1.2T23.82.2%+761%

The filter, in full: Innovation leaders, companies reinvesting heavily in R&D (≥10% of revenue) where it's translating into growth (revenue up >8%/yr) on a sound balance sheet. The secular-growth / moat candidates a value screen misses. Heaviest R&D first. (Covers names that report R&D.) Figures come from SEC filings and end-of-day closes. A screen is a starting point for reading, not a recommendation.

Open this screen in the interactive screener to change the filters or sort it your own way.